Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--
KZR Kezar Life Sciences
6.780-0.050-0.73%
Close
02/07 16:00 ET
High
6.920
Open
6.830
Turnover
2.66M
Low
6.600
Pre Close
6.830
Volume
394.72K
Intraday
5D
1D
1W
1M
1Q
1Y
Price Forecast
News
Comment
Insider Selling: Kezar Life Sciences, Inc. (NASDAQ:KZR) Major Shareholder Sells 25,000 Shares of Stock
Kezar Life Sciences, Inc. (NASDAQ:KZR – Get Rating) major shareholder Morningside Venture Investment sold 25,000 shares of the business's stock in a transaction on Friday, February 3rd. The shares we
Kezar Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Morningside Venture Investment Sells 30,000 Shares of Kezar Life Sciences, Inc. (NASDAQ:KZR) Stock
Kezar Life Sciences, Inc. (NASDAQ:KZR – Get Rating) major shareholder Morningside Venture Investment sold 30,000 shares of the firm's stock in a transaction that occurred on Monday, January 30th. The
Insider Selling: Kezar Life Sciences, Inc. (NASDAQ:KZR) Major Shareholder Sells $342,500.00 in Stock
Kezar Life Sciences, Inc. (NASDAQ:KZR – Get Rating) major shareholder Morningside Venture Investment sold 50,000 shares of the firm's stock in a transaction on Wednesday, January 25th. The stock was
Morningside Venture Investment Sells 50,000 Shares of Kezar Life Sciences, Inc. (NASDAQ:KZR) Stock
Kezar Life Sciences, Inc. (NASDAQ:KZR – Get Rating) major shareholder Morningside Venture Investment sold 50,000 shares of the company's stock in a transaction on Wednesday, January 25th. The shares
Hilltop GAAP EPS of $0.39, Revenue of $169.78M
BAND, PRTK and OTLY Are Among After Hour Movers
Victory Capital Management Inc. Sells 410,606 Shares of Kezar Life Sciences, Inc. (NASDAQ:KZR)
Victory Capital Management Inc. reduced its stake in Kezar Life Sciences, Inc. (NASDAQ:KZR – Get Rating) by 14.8% during the 3rd quarter, according to its most recent 13F filing with the Securities
Insider Selling: Kezar Life Sciences, Inc. (NASDAQ:KZR) Major Shareholder Sells $41,514.06 in Stock
Kezar Life Sciences, Inc. (NASDAQ:KZR – Get Rating) major shareholder Morningside Venture Investment sold 6,114 shares of the firm's stock in a transaction dated Tuesday, January 17th. The stock was
Insider Selling: Kezar Life Sciences, Inc. (NASDAQ:KZR) Major Shareholder Sells 6,114 Shares of Stock
Kezar Life Sciences, Inc. (NASDAQ:KZR – Get Rating) major shareholder Morningside Venture Investment sold 6,114 shares of the company's stock in a transaction dated Tuesday, January 17th. The shares
Company Overview
More
Kezar Life Sciences, Inc. is a clinical-stage biopharmaceutical company which engages in the development of novel small molecule therapeutics to treat autoimmunity and cancer in South San Francisco and California. Its product pipeline include KZR-616, KZR-261, and KZR-TBD. The company was founded by John Fowler, Christopher J. Kirk, and Jack Taunton on February 20, 2015 and is headquartered in South San Francisco, CA.
CEO： Mr. John Franklin Fowler
Market： NASDAQ
Listing Date： 06/21/2018
Paper Trade
More
Hot List
TradeSearchNews
SymbolLatest price%Chg
Loading...
Watchlist
No Stock Yet